Targets of NRF2 such as glucose-6-phosphate dehydrogenase (G6PD) and glutamate–cysteine ligase complex modifier subunit (GCLM) have prominent roles in promoting cancer cell survival by neutralizing the toxic effects of oxidative stress. This evidence concerns the gene G6PD and cancer.